Flare Therapeutics
At Flare, Miljan focuses on solving complex biological questions related to disease and small molecule therapeutics by applying state-of-the-art, quantitative proteomic approaches.
With 10 years of experience in mass spectrometry and proteomics, Miljan has applied his expertise to various disease areas, including in vivo modeling, cancer, diabetes, and anti-microbial peptides. More recently, his main focus was on method development to enable the discovery of chemical probes for undruggable proteins.
This person is not in any offices
Flare Therapeutics
Flare is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines.